Deprescribing in older patients with hyperpolypharmacy: a cluster-randomised trial in primary care
Age and Ageing · 02.07.2026 · 55 (7)
DOI: 10.1093/ageing/afag209 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Age and Ageing, online erschienen am 19.07.2026. Verfasst von Gert Baas und 8 weiteren Autor:innen. Beteiligte Einrichtung: SIR Institute for Pharmacy Practice and Policy, Leiden, ZH, The Netherlands. Hauptthemen laut MEDLINE: Polypharmacy, Deprescriptions, Primary Health Care, Pharmacists. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Polypharmacy increases the risk of adverse drug events and potentially preventable hospital admissions. Deprescribing may reduce medication-related harm, and a clinical medication review (CMR) provides an opportunity to support this.
Objective
To investigate the effect of a deprescribing-focused CMR by trained pharmacists on the number of reduced and stopped medications among patients aged ≥75 years with hyperpolypharmacy using multidose-drug-dispensing (MDD)-systems.
Methods
In this cluster-randomised controlled trial, pharmacists were trained to perform a deprescribing-focused CMR, while control pharmacies provided usual care. Eligible patients were aged ≥75 years, had hyperpolypharmacy and used MDD. Dispensing data were used to determine the number of reduced and stopped medications per patient after 6 months (primary outcome). Secondary outcomes were: total number of medications, health problems and quality-of-life (EQ-5D-5L, EQ-VAS). A generalised linear mixed model was used for the primary outcome.
Results
A total of 318 patients from 58 pharmacies were enrolled (155 intervention, 163 control). At 6 months, patients in the intervention group had significantly more medications deprescribed than those in the control group (mean 2.5 vs. 1.7 per patient; mean difference 0.79, 95% CI 0.29–1.28; P = .002). There was no significant between-group difference in the total number of medications at 6 months (intervention −0.30 vs. control +0.12; P = .108). No significant differences were observed in health problems or quality-of-life.
Conclusion
Deprescribing-focused CMRs by trained pharmacists successfully increased reduction and stopping of medications in older patients with hyperpolypharmacy using MDD-systems, while no changes in health problems or health-related quality of life could be observed over 6 months.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- SIR Institute for Pharmacy Practice and Policy, Leiden, ZH, The Netherlands.
- Department of Pharmaceutical Sciences, Utrecht University, Utrecht 125, The Netherlands.
- Public Health and Primary Care, Leiden University Medical Center, Leiden, The Netherlands.
- Department of Family Medicine, Maastricht University, Maastricht, LI, The Netherlands.
- Dutch College of General Practitioners (NHG), Utrecht, The Netherlands.
- Clinical Pharmacy & Pharmacology, University of Groningen, University Medical Center Groningen, PO Box 30001 EB71, Groningen 9700RB, The Netherlands.
ORCID-Profile: Gert Baas, Jacobijn Gussekloo, Marcel L Bouvy
Zitieren
APA
Baas, G., Heringa, M., Verdoorn, S., Kwint, H. F., Badawy, E., Gussekloo, J., Burgers, J., Denig, P., & Bouvy, M. L. (2026). Deprescribing in older patients with hyperpolypharmacy: a cluster-randomised trial in primary care. Age and Ageing, 55(7). https://doi.org/10.1093/ageing/afag209
Vancouver
Baas G, Heringa M, Verdoorn S, Kwint HF, Badawy E, Gussekloo J, et al. Deprescribing in older patients with hyperpolypharmacy: a cluster-randomised trial in primary care. Age and Ageing. 2026;55(7). doi:10.1093/ageing/afag209
BibTeX
@article{Baas2026,
author = {Baas, Gert and Heringa, Mette and Verdoorn, Sanne and Kwint, Henk-Frans and Badawy, Eman and Gussekloo, Jacobijn and Burgers, Jako and Denig, Petra and Bouvy, Marcel L},
title = {Deprescribing in older patients with hyperpolypharmacy: a cluster-randomised trial in primary care},
journal = {Age and Ageing},
year = {2026},
volume = {55},
number = {7},
doi = {10.1093/ageing/afag209}
}
EUVIMED